These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22612749)

  • 1. Use of intravenous immunoglobulin in the treatment of immune-mediated demyelinating diseases of the nervous system.
    Winkelmann A; Zettl UK
    Curr Pharm Des; 2012; 18(29):4570-82. PubMed ID: 22612749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin in neurological disease: a specialist review.
    Wiles CM; Brown P; Chapel H; Guerrini R; Hughes RA; Martin TD; McCrone P; Newsom-Davis J; Palace J; Rees JH; Rose MR; Scolding N; Webster AD
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):440-8. PubMed ID: 11909900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins].
    Pouget J
    Rev Prat; 1994 Nov; 44(18):2404-6. PubMed ID: 7855497
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immunoglobulin treatment in peripheral nerve disorders--indications, mechanisms of action and side-effects.
    Hahn AF
    Curr Opin Neurol; 2000 Oct; 13(5):575-82. PubMed ID: 11073366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper Extremity Multifocal Neuropathy in a 10-Year-Old Boy Associated With NS6S Disaccharide Antibodies.
    Edelman F; Naddaf E; Waclawik AJ
    J Child Neurol; 2015 Jun; 30(7):945-8. PubMed ID: 25038124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arthritis associated with circulating immune complexes following administration of intravenous immunoglobulin therapy in a patient with chronic inflammatory demyelinating polyneuropathy.
    Lisak RP
    J Neurol Sci; 1996 Jan; 135(1):85-8. PubMed ID: 8926503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic principles of intravenous immunoglobulin (IVIg) treatment.
    Stangel M; Pul R
    J Neurol; 2006 Sep; 253 Suppl 5():V18-24. PubMed ID: 16998749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin use for neurologic diseases.
    Koski CL; Patterson JV
    J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin in therapy of peripheral neuropathy.
    Gorshtein A; Levy Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):271-9. PubMed ID: 16391402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
    Stangel M; Hartung HP; Marx P; Gold R
    J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoglobulins and physiopathology: actual indications].
    Mouthon L; Guilpain P
    Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Hahn AF
    Neurology; 1998 Dec; 51(6 Suppl 5):S16-21. PubMed ID: 9851725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulins in dermatology. Part 1: biological mechanisms and methods of administration.
    Forbat E; Ali FR; Al-Niaimi F
    Clin Exp Dermatol; 2018 Jul; 43(5):513-517. PubMed ID: 29774583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of intravenous immunoglobulin in neurological disorders].
    Steck AJ
    Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.